
ProBioGen Announces Expansion of Commercial Licenses with Emergent BioSolutions for AGE1.CR® Viral Vaccine Manufacturing Production Platform
ProBioGen announced that it has signed an agreement with Emergent BioSolutions for a non-exclusive commercial multi-prod…